https://stock.noler.com/us/stock/blueprint-medicines-corporation https://stock.noler.com/us/stock/blueprint-medicines-corporation/accounts-payable https://stock.noler.com/us/stock/blueprint-medicines-corporation/accounts-receivable https://stock.noler.com/us/stock/blueprint-medicines-corporation/accrued-liabilities-current https://stock.noler.com/us/stock/blueprint-medicines-corporation/accrued-professional-fees-current https://stock.noler.com/us/stock/blueprint-medicines-corporation/accumulated-depreciation https://stock.noler.com/us/stock/blueprint-medicines-corporation/additional-paid-in-capital https://stock.noler.com/us/stock/blueprint-medicines-corporation/advertising-expense https://stock.noler.com/us/stock/blueprint-medicines-corporation/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/blueprint-medicines-corporation/amortization-of-financing-costs https://stock.noler.com/us/stock/blueprint-medicines-corporation/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/blueprint-medicines-corporation/aoci https://stock.noler.com/us/stock/blueprint-medicines-corporation/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/blueprint-medicines-corporation/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/blueprint-medicines-corporation/available-for-sale-debt-amortized-cost-after-allowance-for-credit-loss https://stock.noler.com/us/stock/blueprint-medicines-corporation/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/blueprint-medicines-corporation/available-for-sale-debt-current https://stock.noler.com/us/stock/blueprint-medicines-corporation/available-for-sale-debt-maturities-after-one-through-five-years-amortized-cost https://stock.noler.com/us/stock/blueprint-medicines-corporation/available-for-sale-debt-maturities-after-one-through-five-years-fair-value https://stock.noler.com/us/stock/blueprint-medicines-corporation/available-for-sale-debt-maturities-next-rolling-twelve-months-fair-value https://stock.noler.com/us/stock/blueprint-medicines-corporation/available-for-sale-debt-maturities-rolling-after-year-ten-fair-value https://stock.noler.com/us/stock/blueprint-medicines-corporation/available-for-sale-debt-maturities-rolling-year-six-through-ten-fair-value https://stock.noler.com/us/stock/blueprint-medicines-corporation/available-for-sale-debt-maturities-rolling-year-two-through-five-fair-value https://stock.noler.com/us/stock/blueprint-medicines-corporation/available-for-sale-debt-maturities-within-one-year-amortized-cost https://stock.noler.com/us/stock/blueprint-medicines-corporation/available-for-sale-debt-maturities-within-one-year-fair-value https://stock.noler.com/us/stock/blueprint-medicines-corporation/available-for-sale-debt-noncurrent https://stock.noler.com/us/stock/blueprint-medicines-corporation/available-for-sale-debt-realized-gain-loss https://stock.noler.com/us/stock/blueprint-medicines-corporation/available-for-sale-debt-securities https://stock.noler.com/us/stock/blueprint-medicines-corporation/available-for-sale-debt-unrealized-loss-position https://stock.noler.com/us/stock/blueprint-medicines-corporation/available-for-sale-debt-unrealized-loss-position-12-months-or-longer https://stock.noler.com/us/stock/blueprint-medicines-corporation/available-for-sale-debt-unrealized-loss-position-12-months-or-longer-loss https://stock.noler.com/us/stock/blueprint-medicines-corporation/available-for-sale-debt-unrealized-loss-position-12-months-or-longer-number-of-positions https://stock.noler.com/us/stock/blueprint-medicines-corporation/available-for-sale-debt-unrealized-loss-position-less-than-12-months https://stock.noler.com/us/stock/blueprint-medicines-corporation/available-for-sale-debt-unrealized-loss-position-less-than-12-months-loss https://stock.noler.com/us/stock/blueprint-medicines-corporation/available-for-sale-debt-unrealized-loss-position-less-than-12-months-number-of-positions https://stock.noler.com/us/stock/blueprint-medicines-corporation/available-for-sale-debt-unrealized-loss-position-loss https://stock.noler.com/us/stock/blueprint-medicines-corporation/available-for-sale-debt-unrealized-loss-position-number-of-positions https://stock.noler.com/us/stock/blueprint-medicines-corporation/available-for-sale-gross-realized-gain-loss-net https://stock.noler.com/us/stock/blueprint-medicines-corporation/available-for-sale-gross-unrealized-gain-loss https://stock.noler.com/us/stock/blueprint-medicines-corporation/available-for-sale-unrealized-loss-position-12-months-or-longer-aggregate-losses https://stock.noler.com/us/stock/blueprint-medicines-corporation/available-for-sale-unrealized-loss-position-less-than-12-months-aggregate-losses https://stock.noler.com/us/stock/blueprint-medicines-corporation/basic-shares https://stock.noler.com/us/stock/blueprint-medicines-corporation/capital-expenditures https://stock.noler.com/us/stock/blueprint-medicines-corporation/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/blueprint-medicines-corporation/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/blueprint-medicines-corporation/cash-and-cash-equivalents-fair-value-disclosure https://stock.noler.com/us/stock/blueprint-medicines-corporation/cash-and-equivalents https://stock.noler.com/us/stock/blueprint-medicines-corporation/cash-and-restricted-cash https://stock.noler.com/us/stock/blueprint-medicines-corporation/cash-and-restricted-cash-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/blueprint-medicines-corporation/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/blueprint-medicines-corporation/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/blueprint-medicines-corporation/cash-flow-breakdown https://stock.noler.com/us/stock/blueprint-medicines-corporation/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/blueprint-medicines-corporation/common-stock-value https://stock.noler.com/us/stock/blueprint-medicines-corporation/comprehensive-income https://stock.noler.com/us/stock/blueprint-medicines-corporation/contract-liability https://stock.noler.com/us/stock/blueprint-medicines-corporation/contract-with-customer-asset-accumulated-allowance-for-credit-loss https://stock.noler.com/us/stock/blueprint-medicines-corporation/contract-with-customer-asset-allowance-for-credit-loss-recovery https://stock.noler.com/us/stock/blueprint-medicines-corporation/contract-with-customer-asset-credit-loss-expense https://stock.noler.com/us/stock/blueprint-medicines-corporation/contract-with-customer-liability-noncurrent https://stock.noler.com/us/stock/blueprint-medicines-corporation/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/blueprint-medicines-corporation/cost-of-revenue https://stock.noler.com/us/stock/blueprint-medicines-corporation/costs-and-expenses https://stock.noler.com/us/stock/blueprint-medicines-corporation/cover-page-shares-outstanding https://stock.noler.com/us/stock/blueprint-medicines-corporation/cumulative-effect-on-retained-earnings-net-of-tax https://stock.noler.com/us/stock/blueprint-medicines-corporation/current-assets https://stock.noler.com/us/stock/blueprint-medicines-corporation/current-liabilities https://stock.noler.com/us/stock/blueprint-medicines-corporation/current-portion-of-long-term-debt https://stock.noler.com/us/stock/blueprint-medicines-corporation/debt-issuance-costs-incurred-during-noncash-or-partial-noncash-transaction https://stock.noler.com/us/stock/blueprint-medicines-corporation/debt-issued https://stock.noler.com/us/stock/blueprint-medicines-corporation/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/blueprint-medicines-corporation/debt-maturing-in-year-two https://stock.noler.com/us/stock/blueprint-medicines-corporation/debt-maturing-remainder-of-fiscal-year https://stock.noler.com/us/stock/blueprint-medicines-corporation/deferred-compensation-liability-classified-noncurrent https://stock.noler.com/us/stock/blueprint-medicines-corporation/deferred-compensation-share-based-arrangements-liability-current https://stock.noler.com/us/stock/blueprint-medicines-corporation/deferred-offering-costs https://stock.noler.com/us/stock/blueprint-medicines-corporation/deferred-rent-credit-current https://stock.noler.com/us/stock/blueprint-medicines-corporation/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/blueprint-medicines-corporation/deferred-revenue https://stock.noler.com/us/stock/blueprint-medicines-corporation/deferred-revenue-noncurrent https://stock.noler.com/us/stock/blueprint-medicines-corporation/deferred-tax-asset-interest-carryforward https://stock.noler.com/us/stock/blueprint-medicines-corporation/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/blueprint-medicines-corporation/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/blueprint-medicines-corporation/deferred-tax-assets-gross https://stock.noler.com/us/stock/blueprint-medicines-corporation/deferred-tax-assets-inventory https://stock.noler.com/us/stock/blueprint-medicines-corporation/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/blueprint-medicines-corporation/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/blueprint-medicines-corporation/deferred-tax-assets-other https://stock.noler.com/us/stock/blueprint-medicines-corporation/deferred-tax-assets-tax-credit-carryforwards-general-business https://stock.noler.com/us/stock/blueprint-medicines-corporation/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/blueprint-medicines-corporation/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/blueprint-medicines-corporation/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-deferred-rent https://stock.noler.com/us/stock/blueprint-medicines-corporation/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/blueprint-medicines-corporation/deferred-tax-liabilities-deferred-expense https://stock.noler.com/us/stock/blueprint-medicines-corporation/deferred-tax-liabilities-deferred-expense-capitalized-inventory-costs https://stock.noler.com/us/stock/blueprint-medicines-corporation/deferred-tax-liabilities-deferred-expense-deferred-financing-costs https://stock.noler.com/us/stock/blueprint-medicines-corporation/deferred-tax-liabilities-other https://stock.noler.com/us/stock/blueprint-medicines-corporation/deferred-tax-liabilities-prepaid-expenses https://stock.noler.com/us/stock/blueprint-medicines-corporation/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/blueprint-medicines-corporation/defined-benefit-plan-accumulated-benefit-obligation https://stock.noler.com/us/stock/blueprint-medicines-corporation/defined-benefit-plan-benefit-obligation https://stock.noler.com/us/stock/blueprint-medicines-corporation/defined-benefit-plan-contributions-by-employer https://stock.noler.com/us/stock/blueprint-medicines-corporation/defined-benefit-plan-expected-future-benefit-payments-five-fiscal-years-thereafter https://stock.noler.com/us/stock/blueprint-medicines-corporation/defined-benefit-plan-expected-future-benefit-payments-next-twelve-months https://stock.noler.com/us/stock/blueprint-medicines-corporation/defined-benefit-plan-expected-future-benefit-payments-year-five https://stock.noler.com/us/stock/blueprint-medicines-corporation/defined-benefit-plan-expected-future-benefit-payments-year-four https://stock.noler.com/us/stock/blueprint-medicines-corporation/defined-benefit-plan-expected-future-benefit-payments-year-three https://stock.noler.com/us/stock/blueprint-medicines-corporation/defined-benefit-plan-expected-future-benefit-payments-year-two https://stock.noler.com/us/stock/blueprint-medicines-corporation/defined-benefit-plan-expected-future-employer-contributions-current-fiscal-year https://stock.noler.com/us/stock/blueprint-medicines-corporation/defined-benefit-plan-expected-future-employer-contributions-next-fiscal-year https://stock.noler.com/us/stock/blueprint-medicines-corporation/defined-benefit-plan-fair-value-of-plan-assets https://stock.noler.com/us/stock/blueprint-medicines-corporation/defined-benefit-plan-funded-status-of-plan https://stock.noler.com/us/stock/blueprint-medicines-corporation/defined-benefit-plan-net-periodic-benefit-cost https://stock.noler.com/us/stock/blueprint-medicines-corporation/defined-benefit-plan-pension-plans-with-accumulated-benefit-obligations-in-excess-of-plan-assets-aggregate-accumulated-benefit-obligation https://stock.noler.com/us/stock/blueprint-medicines-corporation/defined-benefit-plan-pension-plans-with-accumulated-benefit-obligations-in-excess-of-plan-assets-aggregate-fair-value-of-plan-assets https://stock.noler.com/us/stock/blueprint-medicines-corporation/defined-benefit-plan-pension-plans-with-accumulated-benefit-obligations-in-excess-of-plan-assets-aggregate-projected-benefit-obligation https://stock.noler.com/us/stock/blueprint-medicines-corporation/defined-contribution-plan-cost-recognized https://stock.noler.com/us/stock/blueprint-medicines-corporation/defined-contribution-plan-employer-discretionary-contribution-amount https://stock.noler.com/us/stock/blueprint-medicines-corporation/defined-contribution-plan-employer-matching-contribution-percent https://stock.noler.com/us/stock/blueprint-medicines-corporation/defined-contribution-plan-employer-matching-contribution-percent-of-match https://stock.noler.com/us/stock/blueprint-medicines-corporation/depreciation https://stock.noler.com/us/stock/blueprint-medicines-corporation/depreciation-and-amortization https://stock.noler.com/us/stock/blueprint-medicines-corporation/diluted-shares https://stock.noler.com/us/stock/blueprint-medicines-corporation/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/blueprint-medicines-corporation/effect-of-exchange-rate-on-cash-and-restricted-cash https://stock.noler.com/us/stock/blueprint-medicines-corporation/effective-tax-rate https://stock.noler.com/us/stock/blueprint-medicines-corporation/employee-related-liabilities-current https://stock.noler.com/us/stock/blueprint-medicines-corporation/entity-listing-par-value-per-share https://stock.noler.com/us/stock/blueprint-medicines-corporation/eps https://stock.noler.com/us/stock/blueprint-medicines-corporation/eps-basic https://stock.noler.com/us/stock/blueprint-medicines-corporation/equity-securities-without-readily-determinable-fair-value-amount https://stock.noler.com/us/stock/blueprint-medicines-corporation/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/blueprint-medicines-corporation/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/blueprint-medicines-corporation/financing-cash-flow https://stock.noler.com/us/stock/blueprint-medicines-corporation/form-d-stocks https://stock.noler.com/us/stock/blueprint-medicines-corporation/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/blueprint-medicines-corporation/general-and-administrative-expense https://stock.noler.com/us/stock/blueprint-medicines-corporation/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/blueprint-medicines-corporation/income-loss-from-per-basic-and-diluted-share https://stock.noler.com/us/stock/blueprint-medicines-corporation/income-tax https://stock.noler.com/us/stock/blueprint-medicines-corporation/income-taxes-paid https://stock.noler.com/us/stock/blueprint-medicines-corporation/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/blueprint-medicines-corporation/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/blueprint-medicines-corporation/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/blueprint-medicines-corporation/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/blueprint-medicines-corporation/increase-decrease-in-contract-with-customer-liability https://stock.noler.com/us/stock/blueprint-medicines-corporation/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/blueprint-medicines-corporation/increase-decrease-in-inventories https://stock.noler.com/us/stock/blueprint-medicines-corporation/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/blueprint-medicines-corporation/increase-decrease-in-other-deferred-liability https://stock.noler.com/us/stock/blueprint-medicines-corporation/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/blueprint-medicines-corporation/increase-decrease-in-other-noncurrent-liabilities https://stock.noler.com/us/stock/blueprint-medicines-corporation/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/blueprint-medicines-corporation/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/blueprint-medicines-corporation/increase-decrease-in-unbilled-receivables https://stock.noler.com/us/stock/blueprint-medicines-corporation/increase-in-restricted-cash https://stock.noler.com/us/stock/blueprint-medicines-corporation/insider-transactions-preferred https://stock.noler.com/us/stock/blueprint-medicines-corporation/insider-transactions-stock-options https://stock.noler.com/us/stock/blueprint-medicines-corporation/insider-transactions-stock-units https://stock.noler.com/us/stock/blueprint-medicines-corporation/interest-and-debt-expense https://stock.noler.com/us/stock/blueprint-medicines-corporation/interest-income-expense-net https://stock.noler.com/us/stock/blueprint-medicines-corporation/interest-income-expense-nonoperating-net https://stock.noler.com/us/stock/blueprint-medicines-corporation/interest-paid-net https://stock.noler.com/us/stock/blueprint-medicines-corporation/interest-payable-current https://stock.noler.com/us/stock/blueprint-medicines-corporation/inventory https://stock.noler.com/us/stock/blueprint-medicines-corporation/inventory-finished-goods-net-of-reserves https://stock.noler.com/us/stock/blueprint-medicines-corporation/inventory-noncurrent https://stock.noler.com/us/stock/blueprint-medicines-corporation/inventory-work-in-process-net-of-reserves https://stock.noler.com/us/stock/blueprint-medicines-corporation/inventory-write-down https://stock.noler.com/us/stock/blueprint-medicines-corporation/investing-cash-flow https://stock.noler.com/us/stock/blueprint-medicines-corporation/investment-income-net-amortization-of-discount-and-premium https://stock.noler.com/us/stock/blueprint-medicines-corporation/investments-and-cash https://stock.noler.com/us/stock/blueprint-medicines-corporation/lease-and-rental-expense https://stock.noler.com/us/stock/blueprint-medicines-corporation/lease-cost https://stock.noler.com/us/stock/blueprint-medicines-corporation/lease-incentive-payable-current https://stock.noler.com/us/stock/blueprint-medicines-corporation/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/blueprint-medicines-corporation/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/blueprint-medicines-corporation/loans-payable-to-bank-current https://stock.noler.com/us/stock/blueprint-medicines-corporation/long-term-debt https://stock.noler.com/us/stock/blueprint-medicines-corporation/long-term-loans-from-bank https://stock.noler.com/us/stock/blueprint-medicines-corporation/maturities-of-available-for-sale-securities https://stock.noler.com/us/stock/blueprint-medicines-corporation/net-cash-from https://stock.noler.com/us/stock/blueprint-medicines-corporation/net-cash-from-financing-activities https://stock.noler.com/us/stock/blueprint-medicines-corporation/net-cash-from-investing-activities https://stock.noler.com/us/stock/blueprint-medicines-corporation/net-cash-from-operating-activities https://stock.noler.com/us/stock/blueprint-medicines-corporation/net-change-in-cash https://stock.noler.com/us/stock/blueprint-medicines-corporation/net-income https://stock.noler.com/us/stock/blueprint-medicines-corporation/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/blueprint-medicines-corporation/net-income-loss-available-to-common-stockholders-diluted https://stock.noler.com/us/stock/blueprint-medicines-corporation/number-of-operating-segments https://stock.noler.com/us/stock/blueprint-medicines-corporation/oci-available-for-sale-adjustment-before-tax https://stock.noler.com/us/stock/blueprint-medicines-corporation/oci-defined-benefit-plans-net-unamortized-gain-loss-arising-net-of-tax https://stock.noler.com/us/stock/blueprint-medicines-corporation/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/blueprint-medicines-corporation/oci-net-of-tax https://stock.noler.com/us/stock/blueprint-medicines-corporation/oci-reclassification-adjustment-from-aoci-for-writedown-of-securities-net-of-tax https://stock.noler.com/us/stock/blueprint-medicines-corporation/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/blueprint-medicines-corporation/operating-cash-flow https://stock.noler.com/us/stock/blueprint-medicines-corporation/operating-expenses https://stock.noler.com/us/stock/blueprint-medicines-corporation/operating-lease-assets https://stock.noler.com/us/stock/blueprint-medicines-corporation/operating-lease-cost https://stock.noler.com/us/stock/blueprint-medicines-corporation/operating-lease-liability https://stock.noler.com/us/stock/blueprint-medicines-corporation/operating-lease-liability-current https://stock.noler.com/us/stock/blueprint-medicines-corporation/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/blueprint-medicines-corporation/operating-lease-payments https://stock.noler.com/us/stock/blueprint-medicines-corporation/operating-lease-payments-due https://stock.noler.com/us/stock/blueprint-medicines-corporation/operating-lease-payments-due-2 https://stock.noler.com/us/stock/blueprint-medicines-corporation/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/blueprint-medicines-corporation/operating-lease-payments-due-current https://stock.noler.com/us/stock/blueprint-medicines-corporation/operating-lease-payments-due-future-minimum-sublease-rentals https://stock.noler.com/us/stock/blueprint-medicines-corporation/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/blueprint-medicines-corporation/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/blueprint-medicines-corporation/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/blueprint-medicines-corporation/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/blueprint-medicines-corporation/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/blueprint-medicines-corporation/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/blueprint-medicines-corporation/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/blueprint-medicines-corporation/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/blueprint-medicines-corporation/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/blueprint-medicines-corporation/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/blueprint-medicines-corporation/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/blueprint-medicines-corporation/operating-leases-rent-expense-net https://stock.noler.com/us/stock/blueprint-medicines-corporation/other-accrued-liabilities-current https://stock.noler.com/us/stock/blueprint-medicines-corporation/other-income https://stock.noler.com/us/stock/blueprint-medicines-corporation/other-long-term-debt-current https://stock.noler.com/us/stock/blueprint-medicines-corporation/other-long-term-debt-noncurrent https://stock.noler.com/us/stock/blueprint-medicines-corporation/other-noncurrent-assets https://stock.noler.com/us/stock/blueprint-medicines-corporation/other-noncurrent-liabilities https://stock.noler.com/us/stock/blueprint-medicines-corporation/other-nonoperating-income-expense https://stock.noler.com/us/stock/blueprint-medicines-corporation/other-operating-activities-cash-flow-statement https://stock.noler.com/us/stock/blueprint-medicines-corporation/other-than-temporary-impairment-loss-debt-securities-available-for-sale https://stock.noler.com/us/stock/blueprint-medicines-corporation/other-than-temporary-impairment-losses-investments-available-for-sale-securities https://stock.noler.com/us/stock/blueprint-medicines-corporation/paid-in-capital-other https://stock.noler.com/us/stock/blueprint-medicines-corporation/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/blueprint-medicines-corporation/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/blueprint-medicines-corporation/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/blueprint-medicines-corporation/payments-for-proceeds-from-other-investing-activities https://stock.noler.com/us/stock/blueprint-medicines-corporation/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/blueprint-medicines-corporation/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/blueprint-medicines-corporation/payments-to-acquire-available-for-sale-debt https://stock.noler.com/us/stock/blueprint-medicines-corporation/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/blueprint-medicines-corporation/preferred-shares-facts https://stock.noler.com/us/stock/blueprint-medicines-corporation/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/blueprint-medicines-corporation/preferred-stock-shares-authorized https://stock.noler.com/us/stock/blueprint-medicines-corporation/preferred-stock-shares-issued https://stock.noler.com/us/stock/blueprint-medicines-corporation/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/blueprint-medicines-corporation/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/blueprint-medicines-corporation/pretax-income https://stock.noler.com/us/stock/blueprint-medicines-corporation/proceeds-from-bank-debt https://stock.noler.com/us/stock/blueprint-medicines-corporation/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/blueprint-medicines-corporation/proceeds-from-issuance-of-other-long-term-debt https://stock.noler.com/us/stock/blueprint-medicines-corporation/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/blueprint-medicines-corporation/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/blueprint-medicines-corporation/proceeds-from-payments-for-other-financing-activities https://stock.noler.com/us/stock/blueprint-medicines-corporation/proceeds-from-repayments-of-other-long-term-debt https://stock.noler.com/us/stock/blueprint-medicines-corporation/proceeds-from-repayments-of-secured-debt https://stock.noler.com/us/stock/blueprint-medicines-corporation/proceeds-from-stock-issued https://stock.noler.com/us/stock/blueprint-medicines-corporation/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/blueprint-medicines-corporation/profit-loss https://stock.noler.com/us/stock/blueprint-medicines-corporation/property-plant-and-equipment-gross https://stock.noler.com/us/stock/blueprint-medicines-corporation/property-plant-equipment https://stock.noler.com/us/stock/blueprint-medicines-corporation/provision-for-doubtful-accounts https://stock.noler.com/us/stock/blueprint-medicines-corporation/public-float https://stock.noler.com/us/stock/blueprint-medicines-corporation/purchase-obligation https://stock.noler.com/us/stock/blueprint-medicines-corporation/purchase-obligations-balance-sheet-amount https://stock.noler.com/us/stock/blueprint-medicines-corporation/realized-investment-gains-losses https://stock.noler.com/us/stock/blueprint-medicines-corporation/repayments-of-bank-debt https://stock.noler.com/us/stock/blueprint-medicines-corporation/repayments-of-long-term-capital-lease-obligations https://stock.noler.com/us/stock/blueprint-medicines-corporation/repayments-of-secured-debt https://stock.noler.com/us/stock/blueprint-medicines-corporation/research-and-development https://stock.noler.com/us/stock/blueprint-medicines-corporation/restricted-cash https://stock.noler.com/us/stock/blueprint-medicines-corporation/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/blueprint-medicines-corporation/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/blueprint-medicines-corporation/restricted-cash-and-cash-equivalents-noncurrent https://stock.noler.com/us/stock/blueprint-medicines-corporation/restricted-cash-current https://stock.noler.com/us/stock/blueprint-medicines-corporation/restricted-cash-noncurrent https://stock.noler.com/us/stock/blueprint-medicines-corporation/retained-earnings https://stock.noler.com/us/stock/blueprint-medicines-corporation/revenue https://stock.noler.com/us/stock/blueprint-medicines-corporation/revenue-from-contract-with-customer-including-assessed-tax https://stock.noler.com/us/stock/blueprint-medicines-corporation/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/blueprint-medicines-corporation/secured-debt-current https://stock.noler.com/us/stock/blueprint-medicines-corporation/secured-long-term-debt https://stock.noler.com/us/stock/blueprint-medicines-corporation/sga-expense https://stock.noler.com/us/stock/blueprint-medicines-corporation/shareholders-equity https://stock.noler.com/us/stock/blueprint-medicines-corporation/shares-authorized https://stock.noler.com/us/stock/blueprint-medicines-corporation/shares-issued https://stock.noler.com/us/stock/blueprint-medicines-corporation/shares-issued-shares-conversion-of-convertible-securities https://stock.noler.com/us/stock/blueprint-medicines-corporation/stock-award-compensation-cost https://stock.noler.com/us/stock/blueprint-medicines-corporation/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/blueprint-medicines-corporation/stock-award-number-of-additional-shares-authorized https://stock.noler.com/us/stock/blueprint-medicines-corporation/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/blueprint-medicines-corporation/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/blueprint-medicines-corporation/stock-award-options-other-share-increase-decrease-in-period-average-exercise-price https://stock.noler.com/us/stock/blueprint-medicines-corporation/stock-based-compensation https://stock.noler.com/us/stock/blueprint-medicines-corporation/stock-compensation-allocation-of-recognized-period-costs-capitalized-amount https://stock.noler.com/us/stock/blueprint-medicines-corporation/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/blueprint-medicines-corporation/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/blueprint-medicines-corporation/stock-issued-new-shares-sold https://stock.noler.com/us/stock/blueprint-medicines-corporation/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/blueprint-medicines-corporation/stock-issued-shares-issued-shares-espps https://stock.noler.com/us/stock/blueprint-medicines-corporation/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/blueprint-medicines-corporation/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/blueprint-medicines-corporation/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/blueprint-medicines-corporation/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/blueprint-medicines-corporation/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/blueprint-medicines-corporation/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/blueprint-medicines-corporation/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/blueprint-medicines-corporation/stock-options-other-increases-decreases-in-period https://stock.noler.com/us/stock/blueprint-medicines-corporation/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/blueprint-medicines-corporation/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/blueprint-medicines-corporation/stock-options-outstanding-number https://stock.noler.com/us/stock/blueprint-medicines-corporation/stock-options-vested-and-expected-to-vest-exercisable-aggregate-intrinsic-value https://stock.noler.com/us/stock/blueprint-medicines-corporation/stock-options-vested-and-expected-to-vest-exercisable-average-exercise-price https://stock.noler.com/us/stock/blueprint-medicines-corporation/stock-options-vested-and-expected-to-vest-exercisable-number https://stock.noler.com/us/stock/blueprint-medicines-corporation/stock-split-ratio https://stock.noler.com/us/stock/blueprint-medicines-corporation/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/blueprint-medicines-corporation/sublease-income https://stock.noler.com/us/stock/blueprint-medicines-corporation/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/blueprint-medicines-corporation/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/blueprint-medicines-corporation/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/blueprint-medicines-corporation/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/blueprint-medicines-corporation/tax-rate-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/blueprint-medicines-corporation/tax-rate-reconciliation-nondeductible-expense-research-and-development https://stock.noler.com/us/stock/blueprint-medicines-corporation/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/blueprint-medicines-corporation/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/blueprint-medicines-corporation/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/blueprint-medicines-corporation/tax-rate-reconciliation-tax-credits-foreign https://stock.noler.com/us/stock/blueprint-medicines-corporation/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/blueprint-medicines-corporation/temporary-equity-dividends-adjustment https://stock.noler.com/us/stock/blueprint-medicines-corporation/total-assets https://stock.noler.com/us/stock/blueprint-medicines-corporation/total-contract-liability https://stock.noler.com/us/stock/blueprint-medicines-corporation/total-liabilities https://stock.noler.com/us/stock/blueprint-medicines-corporation/total-liabilities-and-equity https://stock.noler.com/us/stock/blueprint-medicines-corporation/total-long-term-debt https://stock.noler.com/us/stock/blueprint-medicines-corporation/unrealized-gain-on-securities https://stock.noler.com/us/stock/blueprint-medicines-corporation/unrealized-loss-on-securities https://stock.noler.com/us/stock/blueprint-medicines-corporation/unrecognized-tax-benefits https://stock.noler.com/us/stock/blueprint-medicines-corporation/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/blueprint-medicines-corporation/utb-increase-from-settlements https://stock.noler.com/us/stock/blueprint-medicines-corporation/utb-interest-on-income-taxes-accrued https://stock.noler.com/us/stock/blueprint-medicines-corporation/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/blueprint-medicines-corporation/warrants-and-rights-outstanding https://stock.noler.com/us/stock/blueprint-medicines-corporation/weighted-average-number-of-share-outstanding-basic-and-diluted